FDA approves skin cancer vaccine by...? — December 31, 2027

56% chance

Yes56%

Buy Yes57¢58¢ after fees

No44%

Buy No44¢45¢ after fees

Resolves: Dec 31, 2027
Volume: $194.5K
24h: $5.4K
Liquidity: $7.9K

Listed on 1 venue

Chance over time

Yes price, by venue

Polymarket USCFTC-regulated

Deposit $10, get $25

Trading bonus for new sign-ups.

Claim offer 1 / 5

Sponsored · We may earn a commission · 18+ · Trade responsibly · 1-800-GAMBLER

Signals

Quiet market: no big moves or venue gaps in the last 24 hours.

Every venue’s price

1 venue

Chance

Best

Yes56%—57¢

57¢58¢ after fees

No44%—44¢

44¢45¢ after fees

Each share pays $1 if it’s right. Green marks the cheapest venue after fees; every price opens that venue’s market.

Before you trade

Fee Impact at These Prices

Polymarketat 57¢: exit costs ~0.98¢/contract

Full calculator

How each venue settles it

Polymarket (global)

This market will resolve to "Yes" if the U.S. Food and Drug Administration (FDA) grants approval of intismeran autogene for any indication by December 31, 2027, 11:59 PM ET. Otherwise, this market will resolve to "No". Intismeran autogene refers to the individualized neoantigen therapy developed by Moderna and Merck and evaluated in the Phase 3 INTerpath-001 trial (NCT05933577), also known as mRNA-4157 and V940, tog…

Full rules on Polymarket (global) ↗

About this market

Category: Culture
Event: FDA approves skin cancer vaccine by...?
Resolves: Fri, December 31, 2027